Conivaptan (CI-1025, YM087), a combined vasopressin V-1A/V-2 receptor antagonist, reduces pulmonary capillary wedge pressure independent of baseline serum sodium or vasopressin levels in heart failure patients

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Smith, WB; Russell, S; Ghali, JK; Painchaud, CA; Selaru, P; Ghazzi, MM; Konstam, MA; Udelson, JE

Published Date

  • February 1, 2001

Published In

Volume / Issue

  • 37 / 2

Start / End Page

  • 172A - 173A

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0735-1097